Tag: GlobeNewswire

SCOTTSDALE, Ariz., Oct. 07, 2026 (GLOBE NEWSWIRE) — WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that, as part of its ongoing board refreshment efforts, the WillScot Board of Directors (the “Board”) has unanimously elected Donald (Don) Slager as an independent director effective October 7, 2026.

Worthing Jackman, Executive Chairman of WillScot, commented, “We are fortunate to welcome Don to WillScot’s Board. Our ongoing refreshment process is focused on maintaining the right mix of skills, experience and perspectives to support the Company’s long-term success. Don’s strategic and operational leadership, corporate governance expertise and experience guiding businesses through transformation and complex operating environments will further strengthen the Board and provide valuable perspective as WillScot pursues the opportunities ahead.”

Tim Boswell, CEO of WillScot, commented, “Don has a decades-long record of leading public companies through transformation and creating shareholder value. His experience guiding businesses through periods of growth and evolution will provide valuable strategic insight as we execute our long-term objectives and realize the full potential of WillScot. I have enjoyed getting to know Don and look forward to working with him as we strengthen execution and deliver sustainable value for our shareholders.”

Mr. Slager has been appointed to serve on the Audit Committee and Compensation Committee of the Board.

About Donald (Don) Slager

Mr. Slager served as President and Chief Executive Officer of Republic Services, Inc. (Republic) (NYSE: RSG), a leader in the environmental services industry, from 2011 until his retirement in 2021. Before becoming Chief Executive Officer, he served as Republic’s President and Chief Operating Officer beginning in December 2008. He previously served as President and Chief Operating Officer of Allied Waste Industries, Inc. (Allied Waste) from 2005 until its merger with Republic in 2008 and as Allied Waste’s Executive Vice President and Chief Operating Officer from 2003 to 2004. Mr. Slager also served as a Director of Republic from 2010 to 2021.

An experienced public company director, Mr. Slager currently serves on the boards of Martin Marietta Materials, Inc. (NYSE: MLM) and Eastman Chemical Company (NYSE: EMN). At Martin Marietta, a leading supplier of aggregates and other building materials, he is Lead Independent Director and a member of the Executive Committee and Nominating & Corporate Governance Committee, and Chair of the Management Development & Compensation Committee. At Eastman Chemical, a global specialty materials company, he is an independent director and a member of the Audit Committee, Finance Committee, and Environmental, Safety & Sustainability Committee.

About WillScot

WillScot (Nasdaq: WSC) is a leading provider of innovative turnkey space solutions in North America, helping customers keep projects moving and operations running. The Company partners with critical industries including construction, manufacturing, healthcare, government, energy and education to deliver the right solutions coupled with a high level of customer service. WillScot’s comprehensive portfolio of products – including modular complexes, dry and cold storage containers, blast-resistant buildings, clearspan industrial structures, fencing, and add-on furnishings and equipment – is customizable and flexible to support any project need. Headquartered in Scottsdale, Ariz., WillScot operates from a network of approximately 240 branch locations in the U.S., Canada, and Mexico.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended. The words “estimates,” “expects,” “anticipates,” “believes,” “forecasts,” “plans,” “intends,” “may,” “will,” “should,” “shall,” “outlook,” “guidance,” “see,” “have confidence” and variations of these words and similar expressions identify forward-looking statements, which are generally not historical in nature. Forward-looking statements are subject to a number of risks, uncertainties, assumptions and other important factors, many of which are outside our control, which could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that these forward-looking statements are based on reasonable assumptions, they are predictions and we can give no assurance that any such forward-looking statement will materialize. Any forward-looking statement speaks only at the date on which it is made, and the Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact Information

Investor inquiries:
Charlie Wohlhuter
Investors@willscot.com

Media inquiries:
Juliana Welling
Media@willscot.com

REDWOOD CITY, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper” or the “Company”), a clinical stage biotechnology company focused on the design and development of innovative therapies to treat immune-mediated diseases, today reported that it has commenced an offer to purchase (the “Offer”) any and all of its outstanding warrants to purchase shares of its common stock, par value $0.0001 per share (the “Common Stock”), that were issued in its underwritten public offering on September 18, 2025 (the “Warrants”). The purchase price is $0.324 in cash per Warrant, without interest (the “Offer Purchase Price”). The purpose of the Offer is to reduce the number of shares of Common Stock that would become outstanding upon the exercise of the Warrants, thereby reducing the potential dilutive impact of the Warrants, and providing shareholders and prospective investors greater certainty as to the Company’s capital structure. Warrants tendered in the Offer will be retired and cancelled.

Each Warrant lets its holder buy one share of Common Stock at an exercise price of $2.92, subject to adjustment. Holders may tender as few or as many of their Warrants as they choose. Holders may also exercise their Warrants during the Offer Period in accordance with the terms of the Warrants. Warrants that are not tendered will remain outstanding on their original terms and will expire in accordance with those terms at 5:00 p.m., Eastern Time, on March 18, 2030.

The Offer will be open until one minute after 11:59 p.m., Eastern Time, on November 6, 2026, unless the Company extends it or terminates it earlier (the “Expiration Date”). Holders may withdraw tendered Warrants at any time before the Expiration Date. The Offer is not conditioned on a minimum number of Warrants being tendered. It is subject to certain customary conditions described in the Offer to Purchase, including the absence of any legal action, governmental order or material adverse change that, in the Company’s reasonable judgment, would prohibit, restrict or delay the Offer or materially impair its contemplated benefits. Subject to applicable law, the Company may waive these conditions or extend, amend or terminate the Offer. Promptly after the Expiration Date, the Company will pay the Offer Purchase Price for Warrants that were validly tendered and not withdrawn. If all outstanding Warrants are tendered, the Company would expect to pay out approximately $4.0 million, which will be funded from cash on hand.

The Offer is being made under an Offer to Purchase dated October 7, 2026, and a Tender Offer Statement on Schedule TO dated October 7, 2026. Both are being filed with the Securities and Exchange Commission (“SEC”) and set out the full terms and conditions of the Offer.

The Company’s Common Stock is listed on The Nasdaq Stock Market LLC under the symbols “JSPR”. As of October 6, 2026, there were 12,345,707 Warrants outstanding.

The Company has not hired a dealer manager, information agent or depositary for the Offer. Questions about tender procedures and requests for additional copies of the offer materials, including the Letter of Transmittal and the Notice of Guaranteed Delivery, should be sent to Matthew Ros, the Company’s Chief Operating Officer, at Jasper Therapeutics, Inc., 2200 Bridge Pkwy, Suite #102, Redwood City, CA 94065, by telephone at (650) 549-1400 or by email at kira@argotpartners.com.

About Jasper

Jasper is a clinical stage biotechnology company focused on the design and development of innovative therapies to treat immune-mediated diseases. The company is advancing a pipeline of medicines including KP-104, briquilimab, and KP-701. KP-104 is a potential best-in-class dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other high unmet need nephrology disorders. Briquilimab is an anti-KIT antibody which has demonstrated positive clinical results both as a conditioning agent for stem cell transplant and mast cell mediated diseases such as chronic urticarias and allergic asthma. KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders currently advancing to the clinic.

Forward-Looking Statements
Certain statements contained in this press release are or may be considered “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements can be identified by the fact that they do not relate strictly to historic or current facts. They use words such as “estimate,” “expect,” “intend,” “believe,” “plan,” “anticipate,” “potential,” “projected” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or condition. Jasper cautions that these statements are based upon the current beliefs and expectations of Jasper’s management and are subject to significant risks, uncertainties and assumptions, including, without limitation, risks related to the timing, commencement, duration and completion of the tender offer, the anticipated participation (or lack of participation) of warrant holders, the expected reduction in outstanding warrants, the potential impact on Jasper’s capital structure the uncertainties associated with Jasper’s product candidates, as well as risks associated with the clinical development and regulatory approval of product candidates, including potential delays in the commencement, enrollment and completion of clinical trials; risks related to the inability of Jasper to obtain sufficient additional capital to continue to advance product candidates and its preclinical programs; uncertainties in obtaining successful clinical results for product candidates and unexpected costs that may result therefrom; risks related to the failure to realize any value from product candidates and preclinical programs being developed and anticipated to be developed in light of inherent risks and difficulties involved in successfully bringing product candidates to market; risks associated with the possible failure to realize certain anticipated benefits of the merger, including with respect to future financial and operating results;, and such additional risks and uncertainties contained in the “Risk Factors” section of Jasper’s Annual Reports on Form 10-K for the year ended December 31, 2025, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that Jasper has subsequently filed or may subsequently file with the SEC. Statements regarding future actions, future performance and/or future results including, without limitation, those relating to the timing for completion, and results of, scheduled or additional clinical trials and the FDA’s or other regulatory review and/or approval and commercial launch and sales results (if any) of Jasper’s formulations and product candidates and regulatory filings related to the same, financial projections and targets, including, without limitation, cash runway, operating plans, future capital requirements and the sufficiency of existing cash resources, business strategy, plans and objectives for future operations, statements regarding Jasper and its operations and prospects, may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this press release are inherently uncertain and may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Accordingly, you should not rely upon forward-looking statements as predictions of future events. There is no obligation to update publicly or revise any forward-looking statements for any reason after the date of this press release or to conform these statements to actual results or to changes in Jasper’s expectations, whether as a result of new information, future events, inaccuracies that become apparent after the date hereof or otherwise, except as may be required under applicable securities laws.

Contacts:
Alex Gray (investors)
Jasper Therapeutics
650-549-1454 
agray@jaspertx.com

Argot Partners (investors and media)
kira@argotpartners.com

CARSON CITY, Nev., Oct. 07, 2026 (GLOBE NEWSWIRE) — American Lithium Minerals Inc. (OTC: AMLM) today announced that Worldwide Diversified Holdings, Inc. (“Worldwide”) has agreed to convert its outstanding note into AMLM common shares. Under the agreed structure, Worldwide will facilitate an initial transfer of one AMLM common share for every ten Worldwide common shares, scheduled to be completed in the fourth quarter, advancing AMLM’s capital-markets strategy.

Transaction Overview

• Debt-to-Equity Conversion: Worldwide will convert its outstanding note into AMLM common stock, eliminating the associated debt from AMLM’s balance sheet.
• Shareholder Base Expansion: The conversion and subsequent share distribution will increase AMLM’s shareholder count to more than 500 holders, satisfying a key shareholder-distribution requirement for uplisting to a major national securities exchange.
• Alignment of Interests: Worldwide’s conversion reflects long-term confidence in AMLM’s operational strategy, governance, and capital-markets trajectory.

Strategic Rationale

• Strengthened Balance Sheet: The conversion reduces leverage and improves AMLM’s financial profile ahead of planned acquisitions and development initiatives.
• Uplisting Readiness: Achieving the 500-shareholder threshold is a critical milestone in AMLM’s uplisting roadmap, complementing ongoing audit, governance, and reporting enhancements.
• Enhanced Market Positioning: A broader shareholder base supports improved liquidity, institutional visibility, and long-term value creation.

Management Commentary

Frank Kristan, the Company’s President commented:

“Worldwide’s decision to convert its note into AMLM common equity is a meaningful endorsement of our strategy and a transformative step in our uplisting preparation. This transaction strengthens our balance sheet, expands our shareholder base, and positions AMLM for the next phase of growth.”

AMLM will coordinate with its legal, audit, and capital-markets advisors to finalize all required filings, complete shareholder updates, and advance the company’s uplisting readiness initiatives.

About American Lithium Minerals, Inc.

American Lithium Minerals, Inc. (OTC: AMLM) is a multi-commodity critical minerals exploration company headquartered in Carson City, Nevada. The Company holds active project interests in gold, silver, copper, lithium, and rare earth elements across Nevada (USA), Chile, British Columbia, Yukon and Quebec (Canada), and Western Australia. AMLM’s portfolio includes 11 active project interests, including the Higginsville gold project in Western Australia, silver and copper exploration in Chile, rare earth interests in Quebec, and lithium properties in Nevada.( www.americanmineralresources.com)

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results. Such statements involve a number of risks and uncertainties, including, without limitation, statements regarding the Company’s strategic initiatives, project development plans, expected commodity exposure, anticipated market conditions, the strength of macro tailwinds across critical minerals sectors, and the Company’s ability to advance its multi-commodity portfolio.

Investor Contact

American Lithium Minerals, Inc.
1007 South Street
Carson City, Nevada 89701
Telephone: (775) 587-6137
Email: info@americanmineralresources.com
Website: www.americanmineralresources.com
X / Twitter: American Mineral Resources (OTCID:AMLM) (@AMR_MineralRes) / X
LinkedIn: linkedin.com/company/american-mineral-resources

From left: James Heckman, Roundtable CEO and Founder; Erin Schaefer, Roundtable board member; and Eyal Hertzog, Roundtable co-founder and CTO.

Former head of Global Brand advertising for Google and Global Operations for YouTube unites with Pioneering Veterans, Digital Media Pioneers, James Heckman and Eyal Hertzog, to help bring Roundtable’s transformational AI/DeFi-powered platform to the professional media industry.

SEATTLE, WA, Oct. 07, 2026 (GLOBE NEWSWIRE) — Roundtable (Nasdaq: RTB), an AI/DeFi-powered Enterprise Media OS, today announced that Erin Schaefer has joined its Board of Directors. As a transformative leader in digital innovation, Ms. Schaefer brings a 20-year track record of senior technology leadership, scaling and leading high-stakes, multi-billion-dollar commercial engines for Google, YouTube, and Niantic Games, and more recently, leading General Catalyst ($43B+ AUM) as Chief Operating Officer. Throughout her career, Schaefer has been at the forefront of leading global operations at the frontier of technology.

Ms. Schaefer’s 14-year tenure at Google included serving as Managing Director of Global Operations at YouTube, Managing Director of Global Brand Advertising Strategy, and leading Americas video advertising, where she built the brand commercialization engine from scratch into a $10B+ global revenue business. As COO at General Catalyst, she directed the operating model, capital allocation and Applied AI transformation. As General Manager at Niantic, Erin oversaw US Gaming Studio and Publishing, leading to a multi-billion-dollar exit.

Schaefer’s appointment brings together three pioneering digital media leaders whose careers often intersected as architects and competitors. Before Schaefer led and helped build Google’s brand and YouTube advertising businesses, Heckman architected the landmark Google-MySpace partnership that launched Google’s social advertising marketplace, before his News Corp strategy team architected Hulu’s business model to compete directly with YouTube. Their paths crossed again when Heckman created the world’s largest premium media marketplace, partnering with MSN, Yahoo and AOL – as global media strategy leader at Yahoo – while Schaefer led Google’s directly competing “brand-advertising” business. Earlier still, Roundtable co-founder Eyal Hertzog created MetaCafe, the first social video platform, with tens of millions of users, while inventing the algorithmic personalization feed.

“Partnering with Erin Schaefer brings an extraordinary track record to an already extraordinary team of digital media pioneers,” said Founder James Heckman. “She adds a rare combination of transformational technology leadership and major brand relationships. We’re honored to have Erin help guide our team.”

“My entire career has been about using technology to help passionate voices build sustainable businesses, from YouTube creators to the brands that support them,” said Erin Schaefer. “Professional journalism deserves the same. I believe this elite team of media technology pioneers can give it a brighter future, and James and Eyal Hertzog have built the platform to do it, with the full technology stack of AI, DeFi, and on-chain publishing under one roof.”

Schaefer is uniquely positioned to solidify Roundtable’s elite team, bringing her own major media ecosystem, strategy, and experience and sharing the goal of preserving sovereignty for professional media. Founding team and board members include former Prime Minister and Foreign Minister of Great Britain (hon Liz Truss), inventor of both the social video platform and DeFi technology (Eyal Hertzog), platform engineering head for MSN before leading 6 global platforms (Bill Sornsin), and founder and internet pioneer, James Heckman, responsible for 11 successful digital platforms, including 3 public exits, multiple acquisitions (including 2 to Yahoo, 1 to News Corp), and Publisher of an NFL publishing network.

Ms. Schaefer holds a B.A. in Political Science from Stanford University and an M.B.A. from Harvard Business School. She has served on public, private company, and nonprofit boards, including the Hillsborough Schools Foundation, where she is currently president. The appointment is detailed in the Company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission.

About Roundtable (RTB Digital, Inc.)

Roundtable (NASDAQ: RTB) is an AI/DeFi-powered Enterprise Media Operating System, integrating distribution, publishing, monetization, community, syndication, and DeFi payment operations, powering professional and major media brands. The Web3 platform was developed over years by digital pioneers and co-founders Eyal Hertzog and James Heckman. For more information, visit roundtable.io.

Cautionary Note Regarding Forward-Looking Statements

This press release includes information that constitutes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on the Company’s current beliefs, assumptions, and expectations regarding future events, which in turn are based on information currently available to the Company. Such forward-looking statements include statements that are characterized by future or conditional words such as “may,” “will,” “expect,” “intend,” “anticipate,” “believe,” “estimate,” and “continue” or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. Such forward-looking statements include statements regarding the accretive transactions undertaken in 2026 and future operations and revenues of the company. By their nature, forward-looking statements address matters that are subject to risks and uncertainties. A variety of factors could cause actual events and results to differ materially from those expressed in or contemplated by the forward-looking statements, such as the company being able to maintain its listing on Nasdaq for the common stock, having sufficient capital for its acquisitions, operations and business expansion, and developing its business and capturing users for its services. Annualized and longer period revenue and business estimates are subject to the effect of macroeconomic events, to industry changes, to competitive forces, to client development and retention, to capital availability, and to many other operational factors; therefore, any financial forecasts offered by the Company must take into account the fact that the underlying assumptions may significantly change over time and projected results may substantively increase or decrease. Other risk factors affecting the Company are discussed in detail in the Company’s filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by applicable laws.

Press Contact: press@roundtable.io

IR Contact: ir@roundtable.io

WALTHAM, Mass., Oct. 07, 2026 (GLOBE NEWSWIRE) — Akebia Therapeutics^®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, Dr. Steven Burke, Chief R&D and Medical Officer, and Erik Ostrowski, Chief Financial and Chief Business Officer, will participate in one-on-one meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum on October 14, 2026.

During meetings, management will discuss its commercial products and clinical stage, differentiated pipeline assets for rare kidney diseases.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Waltham, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com  

ANN ARBOR, Mich., Oct. 07, 2026 (GLOBE NEWSWIRE) — Esperion, a company wholly-owned by ARCHIMED, today announced that it has entered into a settlement agreement with Renata Limited (along with an affiliate). This agreement resolves the patent litigation brought by Esperion against Renata in response to Renata’s Abbreviated New Drug Applications (ANDAs) seeking approval to market generic versions of NEXLETOL and NEXLIZET prior to the expiration of the applicable patents. Pursuant to the agreement, Renata has agreed not to market a generic version of either NEXLETOL or NEXLIZET in the United States prior to April 19, 2040, unless certain limited circumstances customarily included in these types of agreements occur.

The pending patent litigation against the remaining defendants (Aurobindo Pharma Limited (along with an affiliate); MSN Pharmaceuticals Inc. (along with an affiliate); and Sandoz Inc.) is ongoing, and there can be no assurance whether such ongoing patent litigation will allow a generic version of NEXLETOL and/or NEXLIZET, as applicable, to be marketed in the U.S. prior to April 19, 2040.

Esperion Therapeutics
Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and delivering innovative cardiometabolic and rare/orphan disease therapies. The Company leverages deep domain expertise in ACLY biology to develop and commercialize transformative medicines for patients worldwide. Esperion currently markets two oral, once-daily, non-statin therapies for patients struggling to maintain their low-density lipoprotein cholesterol (LDL-C) levels and are at risk of cardiovascular disease.

With a broad U.S. commercial infrastructure and global approvals across more than 40 countries, Esperion is well positioned to serve as a partner-of-choice for global innovators seeking U.S. market access through acquisition, in-license, co-promotion and revenue share opportunities. In tandem, the Company is advancing its leadership in ACLY biology to build a diversified pipeline of novel product candidates, including treatments for Primary Sclerosing Cholangitis and renal diseases. For more information, visit esperion.com and follow Esperion on LinkedIn and X.

About ARCHIMED
With offices in Europe, North America and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Animal & Environmental Health, Biopharma Products, Consumer Health, Diagnostics, Healthcare IT, Life Science Tools & Services, and MedTech. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €9 billion across its various funds. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation. For more information about ARCHIMED, please visit www.ARCHIMED.group.

Esperion Contact Information:
Media:
Tiffany Aldrich
corporateteam@esperion.com
(616) 443-8438

Earnings Release and Conference Call Scheduled for November 4, 2026

SAN FRANCISCO, Oct. 07, 2026 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN) today announced that it will issue its third quarter 2026 earnings report after the market closes on Wednesday, November 4, 2026. A conference call has been scheduled to discuss these earnings results at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time.

The conference call can be accessed live via the Sunrun Investor Relations website at https://investors.sunrun.com. An audio replay will be available following the call on the Sunrun Investor Relations website for approximately one month and a transcript of the conference call will be posted to the Sunrun Investor Relations website the following day.

Event:	Sunrun 3Q 2026 Earnings Call
Date:	Wednesday, November 4, 2026
Call Time:	4:30PM ET / 1:30PM PT
Dial-in (toll-free/toll):	(877) 407-5989 / (201) 689-8434
Webcast / Replay:	https://investors.sunrun.com

About Sunrun
Sunrun Inc. (Nasdaq: RUN) is America’s largest provider of home battery storage, solar, and home-to-grid power plants. As the pioneer of home energy systems offered through a no-upfront-cost subscription model, Sunrun empowers customers nationwide with greater energy control, security, and independence. Sunrun supports the grid by providing on-demand dispatchable power that helps prevent blackouts and lower energy costs. Learn more at www.sunrun.com.

Investor & Analyst Contact:

Patrick Jobin
SVP, Deputy CFO & Investor Relations Officer
investors@sunrun.com

Media Contact:

Wyatt Semanek
Sr. Director, Corporate Communications
press@sunrun.com

PLANO, Texas, Oct. 07, 2026 (GLOBE NEWSWIRE) — Deep Isolation Nuclear, Inc. (OTCQB: DBHL) (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today announced that CEO Rod Baltzer and CFO Joe Nelson will present at three upcoming investor conferences, offering investors opportunities to learn more about the Company’s technology, commercialization strategy and progress toward deploying deep borehole disposal for nuclear waste.

On Oct. 8 at 11.30 am ET, Baltzer and Nelson will participate in the Small Cap Growth Virtual Conference by OTC Markets, an online investor event designed to connect publicly traded companies directly with individual and institutional investors, advisers and analysts. The live, interactive format will provide investors an opportunity to hear from Company leadership and submit questions in real time. Baltzer and Nelson will also be available for 1×1 meetings with investors and analysts. Link to the conference: Registration.

On Oct. 14 at 3:30 pm ET, Deep Isolation will present at the Precious Metals & Critical Minerals Virtual Conference, also hosted by OTC Markets. Baltzer and Nelson will discuss Deep Isolation’s approach to nuclear waste disposal and the Company’s role in supporting the infrastructure needed for the continued development and deployment of nuclear energy. Investors attending virtually will have an opportunity to hear the presentation and engage with Company leadership in 1×1 meetings. Link to the conference: Registration.

On Oct. 15, Baltzer and Nelson will present in person at the ThinkEquity Conference 2026 in New York, where Deep Isolation plans to engage with investors and discuss the Company’s commercialization activities, technology portfolio and opportunities arising from growing investment in nuclear energy and its supporting infrastructure.

“These conferences provide important opportunities to engage directly with the investment community as Deep Isolation advances toward commercialization,” said Baltzer. “We are looking forward to sharing our progress, discussing the growing need for practical nuclear waste disposal solutions and outlining how we are working to make deep borehole disposal an important part of the nuclear industry’s future.”

About Deep Isolation

Deep Isolation (OTCQB: DBHL) is the first company to undertake development of technologies for nuclear waste disposal in deep boreholes. Deep Isolation’s solution will offer a unique approach to help countries identify, plan for and complete the necessary steps to dispose of their nuclear waste inventories. With over 100 patents issued to date, Deep Isolation’s technology is designed to leverage proven drilling practices to allow safe isolation of waste deep underground in horizontal, vertical, or slanted borehole repositories. Deep Isolation’s Universal Canister System is engineered to support integrated management of spent fuel and high-level radioactive waste from legacy and advanced reactors across storage, transportation, and eventual disposal.  In January 2026, Deep Isolation launched a full-scale, at-depth deep borehole Commercialization Pilot for its solution at Cameron, Texas, in collaboration with the Deep Borehole Demonstration Center, Halliburton (NYSE: HAL), Amentum (NYSE: AMTM), NAC International (TYO: 7004), and Occlusion Nuclear Solutions.

For more information, visit: https://www.deepisolation.com

Media Contact
Sophie McCallum
media@deepisolation.com

Investor Contact
Caldwell Bailey
InvestorRelations@deepisolation.com

Forward-Looking Statements

Statements contained in this news release that are not historical facts are “forward-looking information” or “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, but are not limited to, statements regarding our plans, objectives and expectations for our business, the future growth of our business and the nuclear energy and nuclear waste disposal industries as a whole, and future benefits expected to arise from our strategic partnerships. In certain cases, forward-looking statements can be identified by the use of words and phrases or variations of words and phrases or statements such as “may,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “will,” “could,” “project,” “target,” “potential,” “continue” and similar expressions. Forward-looking statements are based on management’s belief and assumptions, including current expectations and projections about future events and trends, and on information currently available to management.

Forward-looking statements in this or any other news release are subject to a number of risks, uncertainties, and assumptions that could cause actual results to be materially different from those expressed or implied by such forward-looking statements. Such risks, uncertainties, and assumptions are subject to a number of factors, including, among others: the failure of a market to develop for our deep borehole disposal solutions as quickly as we expect or at all; a failure of demand for our solution to develop sufficiently; regulatory and legal developments, including issues relating to obtaining regulatory approvals or permissions on the timelines we expect or at all; our lack of profitability; delays or failure in our initiative to complete a full-scale, at-depth demonstration of our Universal Canister System and our deep borehole solution; our failure to enter into contracts with customers or, once we do enter into contracts, to continue such contractual relationships or to receive new contract awards; our dependency on governmental contracts and awards and our ability to finalize negotiations on same; our failure to manage our growth effectively or to execute our business plan; our failure to sustain and expand relationships with governmental entities and strategic partners; a failure in the assumptions or analyses we have used in supporting forecasts or plans; our inability to commercialize our products at scale; the development or deployment of other technologies or solutions supplanting or competing with our technologies; challenges to our intellectual property; failures to protect, maintain, enforce, and enhance our intellectual property, and claims by others of intellectual property infringement; political and public perceptions of nuclear energy, including perceptions as to accidents or other high-profile events involving nuclear power facilities or radioactive materials; our liquidity and ability to raise capital; any inability to control operating and project costs and project delays or other project-related problems; security (including cybersecurity) breaches or disruptions; geopolitical, macroeconomic, domestic events or crises, including supply chain disruptions and other risks and uncertainties outside of our control; weather and effects of climate change; and litigation or legal proceedings that may be brought against us.

The foregoing is not an exhaustive list of all the factors that may cause any forward-looking statements to prove inaccurate or our actual results to differ materially from our expectations and forecasts. Moreover, we operate in a highly regulated environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the future events and trends discussed in this release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements, and we cannot guarantee future results, performance, or achievements. Accordingly, readers should not place undue reliance on forward-looking statements. We undertake no obligation to update any forward-looking statements for any reason after the date of this release or to conform these statements to actual results or revised expectations, except as required by law.

Additional information concerning the factors above and other factors will be found in the Company’s public filings with the Securities and Exchange Commission (the “SEC”), including the sections titled “Forward-Looking Statements” and “Risk Factors” in the Company’s Reports on Form 10-K and 10-Q for the fiscal year ended December 31, 2025 and the quarter ending March 31, 2026, respectively, as filed with the SEC on March 30, 2026, our Form S-1, originally filed August 18, 2025 and subsequently amended, our Proxy Statement for our 2026 Annual Meeting as filed on April 29, 2026, and in filings with the SEC that will be made in the future. The Company’s SEC filings are available free of charge at www.sec.gov or upon written request to Deep Isolation at InvestorRelations@deepisolation.com or CorpSec@deepisolation.com.

Vancouver, BC, Oct. 07, 2026 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour”, “SYH” or the “Company”) is pleased to announce the commencement of drilling at the Getty East Uranium Joint Venture (“Getty East” or the “Property”) representing the first phase of drilling in 2026 at this newly established property. The 3,105-hectare Getty East Property, comprising one claim, is a part of the broader Russell Lake project area and joint venture with Denison Mines Corp. (“Denison”) (TSX: DML) (NYSE American: DNN). The Russell Lake Joint Ventures are strategically located in the central portion of the eastern Athabasca Basin of northern Saskatchewan adjacent and proximal to Denison’s flagship Wheeler River project. There is also access to significant regional infrastructure, including an exploration camp, provincial highways, and the provincial power grid.

Russell Lake Project Area Location Map:
https://www.skyharbourltd.com/_resources/images/Russell-Project-Map-V2.jpg

The Skyharbour-operated drill program will be funded by Denison pursuant to its earn-in option at Getty East and is expected to consist of approximately 3,600 metres of diamond drilling in ten to twelve drill holes. This drilling will test the Little Man Lake Uranium Zone (“Little Man Zone”) and priority targets along the interpreted extension of the mineralized Middle Lake trend. Getty East is one of four property joint ventures formed following completion of the strategic transaction with Denison in December 2025, which reorganized the former Russell Lake uranium project into four separate properties and joint ventures. Skyharbour currently holds a 70% interest in Getty East and acts as operator, with Denison holding the remaining 30% and additional earn-in rights to acquire up to a 70% interest in the Property through staged exploration spending totalling C$15 million over seven years.

Jordan Trimble, President and CEO of Skyharbour, stated: “The commencement of drilling at Getty East is yet another milestone in the advancement of the broader Russell Lake project area with our strategic JV partner, Denison Mines. There is notable discovery potential across numerous target areas on the Property, underpinned by uranium mineralization in previous drilling at the Little Man Zone as well as high-grade uranium in historical drilling along strike to the south of Getty East. This current drilling at Getty East is part of a larger planned +15,000-metre, multi-phased drill campaign at Russell in 2026, some which has been completed with assays pending in addition to a final phase of drilling commencing soon at the Wheeler North JV.”

Getty East Project Map:
https://www.skyharbourltd.com/_resources/images/Getty-East-Project-Map-V2.jpg

The Getty East Property hosts the Little Man Zone, as well as the interpreted extension of the Middle Lake trend on claims owned by Cameco Corp. to the south, where historical drilling intersected high-grade uranium mineralization in a number of holes including 22.1% U₃O₈ over 0.9 metres in historical drill hole ML-30. Drill targets have been refined by approximately 36 line-kilometres of modified moving loop time-domain electromagnetic (“MLTDEM”) surveying combined with fixed loop time-domain electromagnetic (“FLTDEM”) surveying on the 108 line-kilometre Middle Lake Extension grid completed earlier this summer, which covered targets on both Getty East and Skyharbour’s neighbouring RL property.

2026 Exploration Overview at Getty East:

The 2026 drill program at Getty East is expected to consist of approximately 3,600 metres in ten to twelve drill holes, with four holes initially planned at the Little Man Zone and six to eight holes on the Middle Lake Extension grid testing EM conductors interpreted to be the extension of the same conductive trend that hosts the high-grade uranium mineralization on the Middle Lake trend. Historical drilling by Uranerz in the 1980’s on this trend, located to the south of Getty East, returned high-grade uranium mineralization in a number of drill holes including 22.1% U₃O₈ over 0.9 metres in ML-30, 11.9% U₃O₈ over 1.0 metre in ML-40, and 1.17% U₃O₈ over 2.5 metres in ML-43.

*The historical drilling results from the Middle Lake trend referenced in this news release, including drill holes ML-30, ML-40 and ML-43, are located on an adjacent property outside of the Getty East Project boundary. Historical uranium assays for these drill holes were reported as % U (Saskatchewan Mineral Assessment Database report 74H04-NE-0076) and have been converted to % U₃O₈ using a factor of 1.1792, with composite grades length-weighted from individual sample assays. Skyharbour’s Qualified Person has not verified this historical information, and mineralization hosted on adjacent properties is not necessarily indicative of mineralization on the Getty East Project.

In preparation for drilling, Skyharbour completed approximately 36 line-kilometres of modified MLTDEM combined with FLTDEM surveying along six lines on the Middle Lake Extension grid earlier this summer, after establishing a 108 line-kilometre grid. The survey, carried out by EarthEX Geophysical Solutions Inc., covered targets on both Getty East and the neighbouring RL Claims properties, and was designed to better define priority conductive corridors associated with the interpreted extension of the Middle Lake trend. The results of this survey, integrated with historical drilling data, will be used to generate and prioritize targets for the current drill program.

At the Little Man Zone, historical drilling on Skyharbour’s Getty East Property outlined an unconformity-hosted uranium zone associated with an unconformity depression that is 10 to 15 metres thick, 25 to 35 metres wide and defined along a strike length of 500 metres. The last drilling in this area was in 1989, prior to modern uranium exploration models, with historical uranium grades ranging from 0.03% up to 0.10% U₃O₈ at around 300 metres depth (SMDI 2429). Skyharbour has reviewed existing geological and geophysical data from previous programs to generate follow-up targets, and its interpretation suggests that the mineralization remains open along strike in both directions and that the basement rocks are entirely untested. The 2015 ground resistivity survey identified several resistivity lows at the unconformity interpreted to represent alteration zones, breaches or plumes in the sandstone and basement rocks associated with graphitic fault zones, several of which are prospective targets that will be prioritized in this program.

Summary of Russell Lake Joint Ventures:

The Russell Lake Joint Ventures encompass a large, advanced-stage uranium exploration land package totalling 73,314 hectares in the eastern Athabasca Basin of northern Saskatchewan. The properties are strategically positioned between Cameco’s Key Lake and McArthur River operations and immediately north, east and south of Denison’s Wheeler River Project.

Following the completion of a major strategic transaction with Denison in 2025, the former Russell Lake project was restructured into four separate joint venture uranium properties: RL, Wheeler North, Getty East, and Wheeler River Inliers. Each property is subject to its own joint venture agreement with operatorship divided between the partners. Skyharbour is the operator at the RL Claims and Getty East, and Denison is the operator at Wheeler North and the Wheeler River Inliers. In aggregate, the strategic transaction included total project consideration of up to C$61.5 million with Skyharbour retaining an 80% interest at RL while Denison can earn up-to 70% at each of the other properties.

The Russell Lake Joint Ventures benefit from excellent regional infrastructure, with the northern extension of Highway 914 traversing the western portion of the land package and a high-voltage provincial powerline running parallel to the road. Across the joint ventures, there are numerous high-priority exploration targets including the Grayling, Fork, Little Man, Christie Lake, Fox Lake Trail, Sphinx, Blue Steel, Taylor Bay, South Russell, and Kowalchuk Zones. In addition, more than 35 kilometres of largely untested prospective electromagnetic conductors occur across the joint venture properties, highlighting the substantial discovery potential.

Qualified Person:

The technical information in this news release has been prepared in accordance with the Canadian regulatory requirements set out in National Instrument 43-101 and reviewed and approved by Serdar Donmez, P.Geo., VP of Exploration for Skyharbour, as well as a Qualified Person.

About Skyharbour Resources Ltd.:

Skyharbour holds an extensive portfolio of uranium exploration projects in Canada’s Athabasca Basin and is well positioned to benefit from improving uranium market fundamentals with interest in forty-four projects covering over 682,100 hectares (1.69M acres) of land. Skyharbour owns a 100% interest in the Moore Uranium Project, which is located 15 kilometres east of Denison’s Wheeler River project and 39 kilometres south of Cameco’s McArthur River uranium mine. Moore is an advanced-stage uranium exploration property with high-grade uranium mineralization at the Maverick Zones. Adjacent to Moore, Skyharbour is advancing several uranium properties within the broader Russell Lake project area with its joint venture partner and large strategic shareholder Denison Mines. Collectively these co-flagship projects host multiple zones of high-grade uranium mineralization across a highly prospective land package with significant exploration upside, and the Company is actively working on these assets through exploration and drilling programs.

Skyharbour now has joint ventures with industry-leaders Denison Mines and Orano Canada Inc. at the Russell Lake properties and the Preston project, respectively. The Company also has several active earn-in option partners, including CSE-listed Nexus Uranium Corp. at the Mann Lake Uranium Project; TSX-V listed North Shore Uranium at the Falcon Project; UraEx Resources at the South Dufferin and Bolt Projects; Future Fuels at the Highway Project; CSE-listed Mustang Energy at the 914W Project; CSE-listed Purecore Metals at the Yurchison Project, and TSX-V listed Terra Clean Energy at the South Falcon East Project. In aggregate, Skyharbour has now signed earn-in option agreements with partners that total to potentially over $79 million in partner-funded exploration expenditures and over $52 million in cash and share payments coming into Skyharbour, assuming that these partner companies complete the earn-ins at their respective projects.

Skyharbour’s goal is to maximize shareholder value through new mineral discoveries, committed long-term partnerships, and the advancement of exploration projects in geopolitically favourable jurisdictions.

Skyharbour’s Uranium Project Map in the Athabasca Basin:
https://www.skyharbourltd.com/_resources/images/SKY_SaskProject_Locator_2025-12-16.jpg

To find out more about Skyharbour Resources Ltd. (TSX-V: SYH) visit the Company’s website at www.skyharbourltd.com.

SKYHARBOUR RESOURCES LTD.

“Jordan Trimble”

Jordan Trimble
President and CEO

For further information contact myself or:

Nicholas Coltura
Corporate Communications & Development Manager
Skyharbour Resources Ltd.
Telephone: 604-558-5847
Toll Free: 800-567-8181
Facsimile: 604-687-3119
Email: info@skyharbourltd.com

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THE CONTENT OF THIS NEWS RELEASE.

Forward-Looking Information:

This news release contains “forward‐looking information or statements” within the meaning of applicable securities laws, which may include, without limitation, completing ongoing and planned work on its projects including drilling and the expected timing of such work programs, other statements relating to the technical, financial and business prospects of the Company, its projects and other matters. All statements in this news release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the price of uranium, the ability to achieve its goals, that general business and economic conditions will not change in a material adverse manner, that financing will be available if and when needed and on reasonable terms. Such forward-looking information reflects the Company’s views with respect to future events and is subject to risks, uncertainties and assumptions, including the risks and uncertainties relating to the interpretation of exploration results, risks related to the inherent uncertainty of exploration and cost estimates and the potential for unexpected costs and expenses, and those filed under the Company’s profile on SEDAR+ at www.sedarplus.ca. Factors that could cause actual results to differ materially from those in forward looking statements include, but are not limited to, continued availability of capital and financing and general economic, market or business conditions, adverse weather or climate conditions, failure to obtain or maintain all necessary government permits, approvals and authorizations, failure to obtain or maintain community acceptance (including First Nations), decrease in the price of uranium and other metals, increase in costs, litigation, and failure of counterparties to perform their contractual obligations. The Company does not undertake to update forward‐looking statements or forward‐looking information, except as required by law.

DALLAS, Oct. 07, 2026 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the third quarter of 2026 after market on Wednesday, October 21, 2026. Executive management will host a conference call and webcast to discuss third quarter 2026 operating results on Wednesday, October 21, 2026, at 5:00 p.m. EDT.

Participants may pre-register for the call by visiting https://events.q4inc.com/analyst/833292417?pwd=y8YwpoQT and will receive a unique PIN number to be used when dialing in for the call for immediate access.

Alternatively, participants may call 833.461.5787 and use the access code 833 292 417 at least fifteen minutes prior to the call to join through an operator.

The live webcast can be found at https://events.q4inc.com/attendee/833292417. Corresponding presentation slides can be accessed on the company’s investor website at https://investors.texascapitalbank.com.

A webcast replay will be available one hour after the conclusion of the call on the company’s investor website.

ABOUT TEXAS CAPITAL BANCSHARES, INC.
Texas Capital Bancshares, Inc. (NASDAQ®: TCBI), a member of the Russell 2000® Index and the S&P MidCap 400®, is the parent company of Texas Capital Bank (“TCB”). Texas Capital is the collective brand name for TCB and its separate, non-bank affiliates and wholly owned subsidiaries. Texas Capital is a full-service financial services firm that delivers customized solutions to businesses, entrepreneurs and individual customers. Founded in 1998, the institution is headquartered in Dallas with offices in Austin, Fort Worth, Houston, San Antonio, Chicago, Los Angeles and New York City, and has a network of clients across the country. With the ability to service clients through their entire lifecycles, Texas Capital has established commercial banking, consumer banking, corporate and investment banking and wealth management capabilities. All services are subject to applicable laws, regulations and service terms. Deposit and lending products and services are offered by TCB. For deposit products, member FDIC. For more information, please visit texascapital.com.

CONTACT: INVESTOR CONTACT
Jocelyn Kukulka, 469.399.8544
jocelyn.kukulka@texascapital.com